Annex
United Kingdom
The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:
Further details on identity and specification of active substance are provided in the review report.
No Common Name, Identification Numbers IUPAC Name Purityf1 Entry into force Expiration of inclusion Specific provisions ‘346 Flutriafol
CAS No: 76674-21-0
CIPAC No: 436
(RS)-2,4′-difluoro-α-(1H-1,2,4-triazol-1-ylmethyl)benzhydryl alcohol ≥ 920 g/kg
(racemate)
Relevant impurities: dimethyl sulphate: max content 0,1 g/kg
dimethylformamide: max content 1 g/kg
methanol: max content 1 g/kg
1 June 2011 31 May 2021 PART A
Only uses as fungicide may be authorised.
PART B
For the implementation of the uniform principles of Annex VI the conclusions of the review report on flutriafol, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 March 2011, shall be taken into account.
In this overall assessment Member States shall:
- (1)
pay particular attention to the protection of the workers’ safety and ensure that conditions of use include the application of adequate personal protective equipment;
- (2)
pay particular attention to the protection of the groundwater, when the active substance is applied in regions with vulnerable soil and/or climatic conditions;
- (3)
pay particular attention to the long-term risk to insectivorous birds.
Conditions of authorisation shall include risk mitigation measures, where appropriate.
The Member States concerned shall ensure that the applicant submits to the Commission confirmatory information as regards:
- (a)
the relevance of the impurities present in the technical specifications;
- (b)
the residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin;
- (c)
the long-term risk to insectivorous birds.
The Member States concerned shall ensure that the applicant submits to the Commission the information set out in point (a) by 1 December 2011, the information set out in points (b) and (c) by 31 May 2013.’
Annotations
Footnotes
- f1
-
Further details on identity and specification of active substance are provided in the review report.